A.L. Jaton

663 total citations
18 papers, 527 citations indexed

About

A.L. Jaton is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A.L. Jaton has authored 18 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in A.L. Jaton's work include Plant and fungal interactions (4 papers), Chemical synthesis and alkaloids (4 papers) and Receptor Mechanisms and Signaling (3 papers). A.L. Jaton is often cited by papers focused on Plant and fungal interactions (4 papers), Chemical synthesis and alkaloids (4 papers) and Receptor Mechanisms and Signaling (3 papers). A.L. Jaton collaborates with scholars based in Japan, United Kingdom and Switzerland. A.L. Jaton's co-authors include Markus Tolnay, Ming Hong, John Q. Trojanowski, Karl‐Heinz Wiederhold, A.R. Dravid, M. G. Spillantini, Claudia Mistl, Jürgen Götz, Kurt Bürki and R. Anthony Crowther and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

A.L. Jaton

18 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.L. Jaton Japan	9	274	247	179	113	101	18	527
Elizabeth Knyihár Hungary	13	254 0.9×	364 1.5×	158 0.9×	50 0.4×	91 0.9×	30	576
Ranbir K. Bhatnagar United States	15	90 0.3×	375 1.5×	193 1.1×	38 0.3×	96 1.0×	31	679
M Assumpció Boronat Spain	9	144 0.5×	404 1.6×	307 1.7×	51 0.5×	32 0.3×	10	572
ROBERTA FRIEDMAN United States	7	371 1.4×	219 0.9×	431 2.4×	81 0.7×	80 0.8×	15	711
Hiroko Tsunekawa Japan	11	143 0.5×	153 0.6×	135 0.8×	60 0.5×	53 0.5×	13	496
Yin‐Guo Lin United States	10	380 1.4×	189 0.8×	261 1.5×	112 1.0×	59 0.6×	14	639
Wiktor Bilecki Poland	16	195 0.7×	363 1.5×	297 1.7×	92 0.8×	29 0.3×	29	681
Gregory J. Sengstock United States	8	74 0.3×	237 1.0×	279 1.6×	120 1.1×	212 2.1×	8	606
S. Croes Belgium	7	422 1.5×	266 1.1×	244 1.4×	88 0.8×	36 0.4×	9	658
Ming‐Kuei Jang United States	9	211 0.8×	188 0.8×	178 1.0×	57 0.5×	98 1.0×	15	473

Countries citing papers authored by A.L. Jaton

Since Specialization

Citations

This map shows the geographic impact of A.L. Jaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Jaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Jaton more than expected).

Fields of papers citing papers by A.L. Jaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Jaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Jaton. The network helps show where A.L. Jaton may publish in the future.

Co-authorship network of co-authors of A.L. Jaton

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Jaton. A scholar is included among the top collaborators of A.L. Jaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Jaton. A.L. Jaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Probst, A., Jürgen Götz, Karl‐Heinz Wiederhold, et al.. (2000). Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathologica. 99(5). 469–481. 287 indexed citations

Markstein, R., Stephan Urwyler, A.L. Jaton, et al.. (1996). SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. Journal of Neural Transmission. 103(1-2). 17–30. 16 indexed citations

Markstein, R., Claes R�deberg, Stephan Urwyler, et al.. (1996). SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity. Journal of Neural Transmission. 103(3). 261–276. 5 indexed citations

Markstein, R., et al.. (1993). SDZ DOD-647, a new clozapine-like atypical neuroleptic drug. Schizophrenia Research. 9(2-3). 244–244. 1 indexed citations

Markstein, R., Max P. Seiler, A.L. Jaton, & U. Briner. (1992). Structure activity relationship and therapeutic uses of dopaminergic ergots. Neurochemistry International. 20. 211–214. 13 indexed citations

Nozulak, Joachim, A.L. Jaton, A. Hofmann, et al.. (1992). Centrally acting .alpha.1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines. Journal of Medicinal Chemistry. 35(3). 480–489. 38 indexed citations

Nozulak, Joachim, A.L. Jaton, A. Hofmann, et al.. (1992). ChemInform Abstract: Centrally Acting α1‐Adrenoceptor Agonists Based on Hexahydronaphth(2,3‐b)‐1,4‐oxazines and Octahydrobenzo(g)quinolines.. ChemInform. 23(23). 1 indexed citations

Temlett, J. A., Niall Quinn, C. D. Marsden, X. Lataste, & A.L. Jaton. (1989). The Antiparkinsonian Activity of CQA 206–291, a New D2 Dopamine Receptor Agonist. Clinical Neuropharmacology. 12(1). 55–59. 2 indexed citations

Markstein, R., Albert Enz, J. M. Vigouret, et al.. (1987). Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8?-ergolene. Journal of Neural Transmission. 69(3-4). 179–199. 10 indexed citations

10.

Jaton, A.L., J. M. Vigouret, Albert Enz, et al.. (1986). Pharmacological profile of the abeorphine 201–678, a potent orally active and long lasting dopamine agonist. Life Sciences. 38(2). 155–163. 13 indexed citations

11.

Markstein, R., A.L. Jaton, J. M. Vigouret, et al.. (1984). PHARMACOLOGICAL PROPERTIES OF 201–678 A NEW DOPAMINE AGONIST. Clinical Neuropharmacology. 7. S430–S430. 4 indexed citations

12.

Dravid, A.R., A.L. Jaton, Albert Enz, & Pascal Frei. (1984). Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra. Brain Research. 311(2). 361–365. 55 indexed citations

13.

Jaton, A.L., et al.. (1980). Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine).. PubMed. 23. 63–74. 4 indexed citations

14.

Vigouret, J. M., et al.. (1978). Neurochemical and Neuropharmacological Investigations with Four Ergot Derivatives: Bromocriptine, Dihydroergotoxine, CF 25-397 and CM 29-712. Pharmacology. 16(1). 156–173. 43 indexed citations

15.

Stadler, P. A., et al.. (1978). ChemInform Abstract: ERGOT ALKALOIDS. 87. NEW ERGOLINES AS SELECTIVE DOPAMINERGIC STIMULANTS. Chemischer Informationsdienst. 9(51). 2 indexed citations

16.

Ruch, W., Peter Marbach, A.L. Jaton, B. Bucher, & W. Doepfner. (1978). Adrenergic and Dopaminergic Control of Growth Hormone Secretion in Urethane Anesthetized Adult Male Rats. Hormone Research. 9(4). 208–224. 4 indexed citations

17.

Ruch, W., A.L. Jaton, B. Bucher, Peter Marbach, & W. Doepfner. (1976). Alpha adrenergic control of growth hormone in adult male rats. Cellular and Molecular Life Sciences. 32(4). 529–531. 24 indexed citations

18.

Jaton, A.L., D. Loew, & J. M. Vigouret. (1976). Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.. PubMed. 56(3). 371P–371P. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact